Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

by Jankowitz, Rachel C, Brufsky, Adam M
Published 2012

Epigenetics in breast cancer: what's new?

by Huang, Yi, Nayak, Shweta, Jankowitz, Rachel, Davidson, Nancy E, Oesterreich, Steffi
Published 2011

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

by Jankowitz, Rachel C, Cooper, Kristine, Erlander, Mark G, Ma, Xiao-Jun, Kesty, Nicole C, Li, Hongying, Chivukula, Mamatha, Brufsky, Adam
Published 2011

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

by Klein, Molly E, Dabbs, David J, Shuai, Yongli, Brufsky, Adam M, Jankowitz, Rachel, Puhalla, Shannon L, Bhargava, Rohit
Published 2013

Molecular drivers of lobular carcinoma in situ

by Logan, Greg J., Dabbs, David J., Lucas, Peter C., Jankowitz, Rachel C., Brown, Daniel D., Clark, Beth Z., Oesterreich, Steffi, McAuliffe, Priscilla F.
Published 2015

Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer

by Wu, Shandong, Berg, Wendie A., Zuley, Margarita L., Kurland, Brenda F., Jankowitz, Rachel C., Nishikawa, Robert, Gur, David, Sumkin, Jules H.
Published 2016